Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
106 Cards in this Set
- Front
- Back
The ANS has 4 classes of drugs. What are they?
|
1. cholinergic agonist
2. cholinergic antagonist 3. adrenergic agonist 4. adrenergic antagonist |
|
What is an adrenergic agonist?
|
A drug that stimulates the adrenergic receptors of the sympathetic NS, either directly (reacting with receptor sites) or indirectly (by increasing NE levels)
|
|
What are cholinergic agonists?
|
chemicals that act on the same site as the NT Ach and increase the activity of the Ach receptor sites throughout the body
Found extensively in parasympathetic NS Their stimulation produces a response similar to what is seen when the parasympathetic NS is activated (parasympathomimetic) |
|
Effects of the Sympathetic NS?
|
1. Increase CO
2. Pulmonary ventilation 3. Routes blood to the muscles (more energy) 4. Raise blood glucose 5. Slows digestion 6. Decreases kidney filtration 7. Pupil dilation *All of these reactions occur at the same time |
|
Effects of the Parasympathetic NS?
|
1. Slow HR
2. Increase gastric secretion 3. Empty bladder/bowel 4. Constrict pupil (miosis) 5. Contract bronchial smooth muscle *All reactions do not have to occur at once, can pick and choose |
|
Give sympathetic and parasympathetic response for:
the heart |
S: increase HR
P: decrease HR |
|
Give sympathetic and parasympathetic response for:
Lung bronchioles |
S: Dilation
P: constriction |
|
Give sympathetic and parasympathetic response for:
Stomach |
S: Decreased secretion and motility
P: Increased secretion and motility |
|
Give sympathetic and parasympathetic response for:
urinary bladder |
S: urination inhibited
P: urination promoted |
|
Give sympathetic and parasympathetic response for:
eye |
S: dilates (mydriasis)
P: constricts (miosis) |
|
What ganglionic NT does the sympathetic preganglionic neuron release?
|
Ach
|
|
In the sympathetic NS, what type of receptor does ganglionic Ach bind to?
|
Nicotinic
|
|
What NT does the sympathetic postganglionic neuron release?
|
NE
|
|
In the sympathetic NS, what type of receptor is located on the effector organ at the 2nd synapse?
|
adrenergic
|
|
What ganglionic NT does the parasympathetic preganglionic neuron release?
|
Ach
|
|
In the parasympathetic NS, what type of receptor does ganglionic Ach bind to?
|
Nicotinic receptor
|
|
In the parasympathetic NS, what NT is released at the 2nd synapse?
|
Ach
|
|
In the parasympathetic NS, at the 2nd synapse, what type of receptor is located on the effector organ?
|
Muscarinic receptor
|
|
Are there ganglia in the somatic nervous system?
|
no
|
|
What NT is released by the somatic NS and which receptor does the effector organ present?
|
Ach
Nicotinic |
|
Size of sympathetic preganglionic neurons? What do these neurons do?
|
short
release Ach to activate nicotinic receptors on postganglionic neurons |
|
Size of sympathetic postsynaptic neurons?
Where do they synapse? What do these neurons release? |
long
on target organs release NE to activate adrenergic receptors on target organs |
|
Size of parasympathetic preganglionic neurons? What do these neurons do?
|
long
release Ach to activate nicotinic receptors on postganglionic neurons |
|
Size of parasympathetic postsynaptic neurons?
Where do they synapse? What do these neurons release? |
short
synapse on a target organ release Ach to activate muscarinic receptors on the target organ |
|
What 2 substances form Ach?
|
coenzyme A and choline
|
|
Which enzyme degrades Ach?
|
acetylcholinesterase
|
|
Receptor(s) that Ach binds to?
|
muscarinic or nicotinic receptors (Ach not selective)
|
|
How is NE created?
|
conversion of:
tyrosine-->dopamine-->NE |
|
Which enzymes degrade NE?
|
1. MAO: monoamine oxidase
2. COMT: catechol-O-methyl-transferase |
|
2 receptors for Ach?
|
muscarinic, nicotinic
*Ach is nonselective |
|
What is the primary Ach receptor in parasympathetic junctions? What effector organs bear this receptor?
|
Muscarinic
GI, bladder, heart, smooth muscle |
|
4 receptors for NE?
|
1. alpha 1
2. alpha 2 3. beta 1 4. beta 2 |
|
NE-alpha 1 receptor causes...
Is it excitatory or inhibitory? |
vasoconstriction .:. increase BP
excitatory |
|
When NE binds to an alpha 2 receptor...
Is it excitatory or inhibitory? |
inhibition of NE release occurs.:. decrease in BP since it prevents NE from acting on alpha 1
inhibitory |
|
NE-beta 1 receptor causes...
Is it excitatory or inhibitory? |
1. tachycardia
2. myocardial contractility excitatory |
|
NE-beta 2 receptor causes...
Is it excitatory or inhibitory? |
1. vasodilation
2. bronchodilation excitatory |
|
What are receptor agonists?
What do they do? |
drugs that mimic NTs
they activate receptors |
|
What are receptor antagonists?
What do they do? |
drugs that block NTs
they block endogenous NTs from activating the receptors |
|
What are 2 primary NTs of the ANS?
|
1. Ach
2. NE |
|
3 equivalents of parasympathomimetic
|
1. mimic ach
2. cholinergic 3. muscarinic agonist |
|
3 equivalents of parasympatholytic?
|
1. block ach
2. anticholinergic 3. muscarinic antagonist |
|
3 equivalents for sympathomimetic?
|
1. mimic NE
2. adrenergic 3. adrenergic agonist |
|
3 equivalents for sympatholytic?
|
1. block NE
2. antiadrenergic 3. adrenergic antagonist |
|
3 types of Adrenergic Agonists?
|
1. alpha- and beta-adrenergic agonists
2. alpha-specific adrenergic agonists 3. beta-specific adrenergic agonists |
|
Give an example of an alpha- and beta- adrenergic agonist
|
dopamine
|
|
Give an example of an alpha-specific adrenergic agonist
|
phenylephrine
|
|
Define adrenergic agonist
|
compounds that mimic the effects of adrenergic nerve stimulation (NE)
|
|
What are direct acting agonists?
|
chemicals that directly bind and activate a given receptor
|
|
What are indirect acting agonists?
|
chemicals that stimulate a receptor by an increased concentration of NT (ex: NE)
|
|
Name 2 uses for adrenergic agonists
|
1. eye drops
2. systemic shock |
|
Dopamine:
What type of adrenergic agonist is it? Indication? MOA? |
alpha and beta adrenergic agonist
Tx: shock MOA: (high dose) stimulates heart and blood pressure; (lower dose) renal dilation *choice drug for shock |
|
Dobutamine:
What type of adrenergic agonist is it? Receptor preference for...? Indication? |
alpha-and beta-adrenergic agonist
beta-1 tx: heart failure |
|
Ephedrine:
What type of adrenergic agonist is it? Indication? MOA? |
alpha-and beta adrenergic agonist
tx: shock, allergies MOA: increases the release of NE and acts on adrenergic receptors |
|
Is dopamine or ephedrine used more often?
|
dopamine
|
|
Alpha- and beta-adrenergic agonists (PK)
abs: met: exc: |
abs: rapidly after injection
met: liver exc: urine |
|
Why do we give alpha- and beta- adrenergic agonists by the IV route?
|
1. they have low oral bioavailibility
2. they have a short half life |
|
Alpha-and Beta-Adrenergic Agonists:
CI |
1. pheochromocytoma: a tumor on adrenal glands that increases the amount of NE and E in the body; giving the drug would cause systemic overload
2. tachyarrhythmias 3. hypovolemia |
|
Alpha-and Beta-Adrenergic Agonists:
caution |
1. peripheral vascular disease (may make atherosclerosis/ Raynaud's disease worse)
|
|
Alpha-and Beta-Adrenergic Agonists:
adverse effects |
CV: arrhythmias, hypertension, palpitations
GI: N/V/ constipation (slows GI) heading, sweating, tension, anxiety extravasion:if leaked out of blood vessel, tissue may necrose and cause cell death *why we need to monitor IV sites |
|
Alpha-and Beta-Adrenergic Agonists:
Drug interaction |
1. TCAs--> increases NE levels
2. MAOIs-->increases NE levels 3. Caffeine-->increases risk of hypertension |
|
What are alpha-specific adrenergic agonists?
|
Drugs that bind primarily to alpha receptors
|
|
Alpha-Specific Adrenergic Agonists:
uses |
Vary, depending on the specific drug
|
|
Phenylephrine
type of adrenergic agonist? specific receptor? use? route? |
Alpha-Specific Adrenergic Agonists
alpha 1 tx: potent vasoconstrictor routes: 1. parenterally (shock) 2. topically (allergic rhinitis) 3. ophthalmically (pupil dilation) |
|
Midodrine
type of adrenergic agonist? specific receptor? use? route? |
alpha-specific adrenergic agonist
alpha 1 tx: orthostatic hypotension (causes vasoconstriction to increase BP; monitor BPs on patient lying down, sitting up, and standing) route: oral |
|
Clonidine
type of adrenergic agonist? specific receptor? use? route? |
Alpha-specific adrenergic agonist
alpha 2 agonist tx: hypertension (reduces sympathetic outflow to decrease BP; watch for extreme hypotension!) route: oral or transdermal |
|
Alpha-Specific Adrenergic Agonists (PK)
abs: dist: met: ex: |
abs: well absorbed
dist: wide met: liver ex: urine |
|
How often should you change the Clonidine Transdermal Patch?
|
every 7 days
|
|
Alpha-Specific Adrenergic Agonists
CI |
1. allergy
2. severe hypertension or tachycardia 3. narrow angle glaucoma *may exacerbate these conditions |
|
Alpha-Specific Adrenergic Agonists
Caution |
1. CVD
2. thyrotoxicosis (increased level of thyroid hormone) 3. diabetes 4. renal or hepatic impairment |
|
Alpha-Specific Adrenergic Agonists
Adverse Effects |
CNS: anxiety, restlessness, depression, fatigue
Blurred vision, light sensitivity CV: arrhythmias, BP changes, peripheral vascular system GI: N/V/anorexia GU: decreased urine output, difficult urinating |
|
Alpha-Specific Adrenergic Agonists
Why shouldn't you stop these suddenly? |
May cause symptoms of withdrawal. Taper down 2-4 days to prevent causing tachycardia or hypotension
|
|
Alpha-Specific Adrenergic Agonists
Drug-Drug Interactions: Never mix Phenylephrine with... |
MAOIs: severe hypotension/headache
|
|
Alpha-Specific Adrenergic Agonists
Drug-Drug Interactions: Never mix Clonidine and... |
TCAs: can decrease anti hypertensive effect of clonidine
|
|
Alpha-Specific Adrenergic Agonists
Drug-Drug Interactions: Never mix midodrine with... |
digoxin,
beta blockers, antipsychotics |
|
Name 2 types of adrenergic blocking antagonists:
|
1. alpha-blockers
2. beta-blockers |
|
What effect to adrenergic alpha blockers have?
|
Vasodilation, leading to decreased BP
|
|
What effect to adrenergic beta blockers have?
|
decrease in the vasoconstrictive effects of NE, causing vasodilation and a decrease in BP
|
|
2 types of cholinergic agonists?
|
1. direct-acting cholinergic agonists
2. indirect-acting cholinergic agonists |
|
What is the prototype drug for direct-acting cholinergic agonists?
|
Bethanechol
|
|
What is the prototype drug for indirect-acting cholinergic agonists?
|
1. agents for Myasthenia Gravis:
Pyridostigmine 2. Agents for Alzheimer Disease Donepezil |
|
What 2 dieases are indirect-acting cholinergic agonists targeted toward?
|
1. myasthenia gravis
2. alzheimer's disease |
|
Direct cholinergic agonists:
use: can these drugs be nonspecific? Tx? |
use: systemic or ophthalmic agents
yes, because our own Ach is nonspecific tx: 1. urinary retention; relaxes sphincter 2. relieve IOP from glaucoma 3. increase secretions in mouth and GI |
|
Which direct cholinergic agonist would you prescribe to treat urinary retention?
|
Bethanechol
|
|
Which direct cholinergic agonists would you prescribe to treat glaucoma?
|
Carbachol
Pilocarpine |
|
Which direct cholinergic agonist would you prescribe to increase secretions in the mouth and GI?
|
Cevimeline
Pilocarpine |
|
Direct cholinergic agonists PK:
abs: oral, topical is the half life short or long in oral administration? |
abs: well absorbed after oral administration
usually not absorbed after topical administration short |
|
Direct Cholinergic Agonists:
CI/ Caution |
1. Allergies
2. Any medical condition that would be exacerbated by parasympathetic effects (bradycardia, hypotension, coronary artery disease) 3. peptic ulcer, GI obstruction 4. ASTHMA (Ach will cause constriction to lungs) 5. bladder obstruction/surgery |
|
Direct Cholinergic Agonists:
Adverse effects |
Related to the parasympathetic NS stimulation
1. CV: bradycardia, hypotension 2. GI: N/V/D, cramps, increased salivation, involuntary defecation 3. Urinary: sense of urgency |
|
Indirect Cholinergic Agonists:
MOA: |
MOA: inhibit acetylcholinesterase (increase the amount of Ach)
|
|
What is myasthenia gravis?
|
a chronic, autoimmune muscle disease; antibodies form against receptors in skeletal muscles, especially in the face, throat, and neck.
may cause severe fatigue |
|
Indirect Cholinergic Agonists and myasthenia gravis:
MOA |
Moa: increase smuscle strength by allowing Ach to accumulate in the synaptic cleft
|
|
What is alzheimer's disease?
|
the progressive loss of Ach-producing neurons and target neurons in the brain
these neurons are linked to memory |
|
Indirect Cholinergic Agonists and alzheimer's disease:
MOA |
MOA: increase Ach concentration in the brain where Ach-producing cells are dying
|
|
Indirect Cholinergic Agonists and alzheimer's disease: PK
abs: dist: met: ex: |
abs: well
dist: well met: liver (CYP450) ex: urine *caution with heptaic impariment |
|
Indirect Cholinergic Agonists and myasthenia gravis: PK
ab: dis: |
abs: well via oral
dist: well |
|
Indirect Cholinergic Agonists:
CI/Caution |
any condition that could be exacerbated by cholinergic stimulation (ie asthma, coronary disease, arrhythmias)
|
|
Indirect Cholinergic Agonists::
Adverse Effects |
*related to parasympathetic nerve stimulation
1. eye: miosis, blurred vision 2. CNS: headache, dizziness, drowsiness 3. CV: bradycardia, hypotension 4. N/V/D, increased salivation, involuntary defecation Urinary: sense of urgency |
|
Indirect Cholinergic Agonists:
Drug-drug interactions |
1. + NSAIDS (motrin): cause GI bleeding
2. Tacrine 3. Theophylline (may increase the level of theophylline to 2x the concentration when given with tacrine; narrow therapeutic level) |
|
Cholinergic Antagonists:
prototype drug |
Atropine
*blocks Ach at the receptor |
|
Cholinergic Antagonists:
MOA |
MOA: blocks the Ach receptors that are responsible for the effects of the parasympathetic postganglionic impulses
*when the parasympathetic system is blocked, the effects of the sympathetic system are more prominently seen |
|
Cholinergic Antagonists:
Atropine What does it do? |
Atropine:
1. inhibits GI secretions 2. bronchial dilation 3. pupillary dilation 4. increased HR *Blocks Ach at muscarinic cholinergic sites |
|
Cholinergic Antagonists:
Scopolamine What does it do? |
1. decreased N/V associated with motion sickness; decrease GI secretions
*patches behind ear on cruise |
|
Cholinergic Antagonists:
CI/Cautions |
Known conditions that may become exacerbated:
1. glaucoma: increase IOP 2. GI obstruction/peptic ulcer 3. bladder obstruction 4. cardiac arrythmias, tachycardia 5. myasthenia gravis 6. hypertension |
|
Cholinergic Antagonists:
Adverse effects |
Caused by systemic blockade of cholinergic receptors
eyes: blurred vision, pupil dilation, photophobia, increased IOP cns: weakness, dizziness gi: dry mouth, altered taste perception, constipation, bloated feelings cv: tachycardia, palpitations gu: urinary hesitancy and retention decreased sweating |
|
Cholinergic Antagonists:
drug-drug interactions with... |
Drugs with anticholinergic activities:
1. antihistamines 2. MAOIs 3. TCAs *the anticholinergic effect will worsen |
|
A cholinergic agonist would cause constriction of the pupil by...
|
Activating the muscarinic receptors
|